<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lipid Modification for CVD Prevention - Quick Reference</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        :root {
            --primary: #2c7be5;
            --secondary: #00d97e;
            --danger: #e63757;
            --warning: #f6c343;
            --light: #f8f9fa;
            --dark: #12263f;
            --gray: #6c757d;
            --card-shadow: 0 0.25rem 1rem rgba(0, 0, 0, 0.075);
            --transition: all 0.3s ease;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            background-color: #f5f7fb;
            color: var(--dark);
            line-height: 1.6;
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }

        header {
            text-align: center;
            padding: 40px 0 30px;
            background: linear-gradient(135deg, var(--primary) 0%, #1a6fc9 100%);
            color: white;
            border-radius: 0 0 20px 20px;
            box-shadow: var(--card-shadow);
            margin-bottom: 40px;
        }

        header h1 {
            font-size: 2.5rem;
            margin-bottom: 10px;
            font-weight: 700;
        }

        header p {
            font-size: 1.2rem;
            opacity: 0.9;
            max-width: 700px;
            margin: 0 auto;
        }

        .algorithm-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(350px, 1fr));
            gap: 25px;
            margin-bottom: 30px;
        }

        .card {
            background: white;
            border-radius: 15px;
            box-shadow: var(--card-shadow);
            padding: 25px;
            transition: var(--transition);
            border-top: 5px solid transparent;
        }

        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 0.5rem 1.5rem rgba(0, 0, 0, 0.1);
        }

        .card.primary {
            border-top-color: var(--primary);
        }

        .card.secondary {
            border-top-color: var(--secondary);
        }

        .card.monitoring {
            border-top-color: var(--warning);
        }

        .card.special {
            border-top-color: var(--danger);
        }

        .card-header {
            display: flex;
            align-items: center;
            margin-bottom: 20px;
            padding-bottom: 15px;
            border-bottom: 1px solid #e9ecef;
        }

        .card-header i {
            font-size: 1.8rem;
            margin-right: 15px;
            padding: 12px;
            border-radius: 50%;
            color: white;
        }

        .primary .card-header i {
            background-color: var(--primary);
        }

        .secondary .card-header i {
            background-color: var(--secondary);
        }

        .monitoring .card-header i {
            background-color: var(--warning);
        }

        .special .card-header i {
            background-color: var(--danger);
        }

        .card-header h2 {
            font-size: 1.6rem;
            font-weight: 600;
        }

        .card-section {
            margin-bottom: 20px;
        }

        .card-section h3 {
            font-size: 1.2rem;
            color: var(--primary);
            margin-bottom: 10px;
            display: flex;
            align-items: center;
        }

        .card-section h3 i {
            margin-right: 8px;
            font-size: 1rem;
        }

        ul {
            list-style-type: none;
            padding-left: 15px;
        }

        li {
            position: relative;
            padding-left: 25px;
            margin-bottom: 8px;
            font-size: 0.95rem;
        }

        li:before {
            content: "•";
            position: absolute;
            left: 0;
            color: var(--primary);
            font-weight: bold;
            font-size: 1.2rem;
        }

        .treatment-box {
            background-color: #f8f9fa;
            border-radius: 8px;
            padding: 15px;
            margin: 15px 0;
            border-left: 4px solid var(--primary);
        }

        .treatment-box h4 {
            font-size: 1.1rem;
            margin-bottom: 10px;
            color: var(--dark);
        }

        .target {
            font-weight: 600;
            color: var(--secondary);
            font-size: 1.1rem;
            padding: 10px 15px;
            background-color: rgba(0, 217, 126, 0.1);
            border-radius: 8px;
            margin: 10px 0;
            display: inline-block;
        }

        .highlight {
            background-color: rgba(44, 123, 229, 0.1);
            padding: 2px 5px;
            border-radius: 4px;
            font-weight: 500;
        }

        .note {
            background-color: #fff3cd;
            border-left: 4px solid var(--warning);
            padding: 15px;
            margin-top: 30px;
            border-radius: 0 8px 8px 0;
        }

        .note p {
            margin: 0;
            font-size: 0.95rem;
        }

        .monitoring-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 15px;
        }

        .monitoring-item {
            background-color: #f8f9fa;
            border-radius: 8px;
            padding: 15px;
        }

        .monitoring-item h4 {
            font-size: 1rem;
            margin-bottom: 8px;
            color: var(--dark);
            display: flex;
            align-items: center;
        }

        .monitoring-item h4 i {
            margin-right: 8px;
            color: var(--warning);
        }

        footer {
            text-align: center;
            padding: 20px 0;
            margin-top: 40px;
            color: var(--gray);
            font-size: 0.9rem;
        }

        @media (max-width: 768px) {
            header h1 {
                font-size: 2rem;
            }
            
            .algorithm-grid {
                grid-template-columns: 1fr;
            }
            
            .monitoring-grid {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>
<body>
    <header>
        <div class="container">
            <h1>Lipid Modification for CVD Prevention</h1>
            <p>Quick Reference Algorithm for Clinical Decision Making</p>
        </div>
    </header>

    <div class="container">
        <div class="algorithm-grid">
            <div class="card primary">
                <div class="card-header">
                    <i class="fas fa-shield-alt"></i>
                    <h2>Primary Prevention</h2>
                </div>
                
                <div class="card-section">
                    <h3><i class="fas fa-user-check"></i> Who to treat:</h3>
                    <ul>
                        <li><span class="highlight">QRISK3 ≥10%</span> (including type 2 diabetes)</li>
                        <li><span class="highlight">Type 1 diabetes</span> if age >40 years, diabetes >10 years, nephropathy, or other CVD risk factors</li>
                        <li><span class="highlight">CKD</span> (eGFR <60 ml/min/1.73m² and/or albuminuria)</li>
                        <li><span class="highlight">Familial hypercholesterolemia</span></li>
                        <li><span class="highlight">Consider for:</span> Age ≥85 years OR age 18-40 with type 1 diabetes</li>
                    </ul>
                </div>
                
                <div class="card-section">
                    <h3><i class="fas fa-pills"></i> First-line treatment:</h3>
                    <div class="treatment-box">
                        <h4>Atorvastatin 20mg</h4>
                        <p>(high-intensity statin)</p>
                    </div>
                </div>
                
                <div class="card-section">
                    <h3><i class="fas fa-bullseye"></i> Target:</h3>
                    <div class="target">&gt;40% reduction in non-HDL cholesterol</div>
                </div>
            </div>

            <div class="card secondary">
                <div class="card-header">
                    <i class="fas fa-heartbeat"></i>
                    <h2>Secondary Prevention</h2>
                </div>
                
                <div class="card-section">
                    <h3><i class="fas fa-user-check"></i> Who to treat:</h3>
                    <ul>
                        <li><span class="highlight">All patients</span> with established CVD</li>
                    </ul>
                </div>
                
                <div class="card-section">
                    <h3><i class="fas fa-pills"></i> First-line treatment:</h3>
                    <div class="treatment-box">
                        <h4>Atorvastatin 80mg</h4>
                        <p>(high-intensity statin)</p>
                        <p style="margin-top: 8px; font-size: 0.9rem; color: var(--gray);">Lower dose if: adverse effects, increased risk, or patient preference</p>
                    </div>
                </div>
                
                <div class="card-section">
                    <h3><i class="fas fa-bullseye"></i> Target:</h3>
                    <div class="target">LDL cholesterol ≤2.0 mmol/L</div>
                    <div class="target">OR non-HDL cholesterol ≤2.6 mmol/L</div>
                </div>
            </div>
        </div>

        <div class="card monitoring">
            <div class="card-header">
                <i class="fas fa-clipboard-check"></i>
                <h2>Monitoring</h2>
            </div>
            
            <div class="monitoring-grid">
                <div class="monitoring-item">
                    <h4><i class="fas fa-vial"></i> Baseline Tests</h4>
                    <ul>
                        <li>Full lipid profile (non-fasting)</li>
                        <li>Liver transaminases (ALT/AST)</li>
                        <li>Renal function</li>
                        <li>Diabetes status</li>
                    </ul>
                </div>
                
                <div class="monitoring-item">
                    <h4><i class="fas fa-calendar-alt"></i> Follow-up</h4>
                    <ul>
                        <li>Repeat lipid profile and liver transaminases at 2-3 months</li>
                        <li>Ongoing monitoring as needed</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class="card special">
            <div class="card-header">
                <i class="fas fa-exclamation-triangle"></i>
                <h2>Special Considerations</h2>
            </div>
            
            <div class="card-section">
                <h3><i class="fas fa-virus"></i> HIV patients</h3>
                <p>All patients with HIV aged ≥40 years should be offered statin treatment regardless of lipid profile or CVD risk</p>
            </div>
            
            <div class="card-section">
                <h3><i class="fas fa-venus"></i> Women of childbearing potential</h3>
                <ul>
                    <li>Contraception required during treatment</li>
                    <li>Stop statins 3 months before conception and during pregnancy</li>
                    <li>Do not restart until breastfeeding ends</li>
                </ul>
            </div>
            
            <div class="card-section">
                <h3><i class="fas fa-exchange-alt"></i> Important interactions</h3>
                <ul>
                    <li>Grapefruit juice</li>
                    <li>Certain medications (check patient information leaflet)</li>
                </ul>
            </div>
            
            <div class="card-section">
                <h3><i class="fas fa-user-md"></i> When to refer</h3>
                <ul>
                    <li>Total cholesterol &gt;9.0 mmol/L or non-HDL &gt;7.5 mmol/L</li>
                    <li>Triglycerides &gt;20 mmol/L (urgent)</li>
                    <li>Triglycerides 10-20 mmol/L (repeat fasting, refer if still &gt;10 mmol/L)</li>
                    <li>Familial hypercholesterolemia suspected</li>
                </ul>
            </div>
        </div>

        <div class="note">
            <p><i class="fas fa-info-circle"></i> Note: Always discuss benefits and risks with patient before initiating treatment. Consider lifestyle modifications alongside pharmacological therapy.</p>
        </div>
    </div>

    <footer>
        <p>© 2023 Lipid Modification for CVD Prevention | Quick Reference Algorithm</p>
    </footer>
</body>
</html>